Muhammad Kashif Amin, MD, MSc, FACP

Professional Background

Dr. Amin is a board-certified internist specializing in inpatient care, with extensive experience in hospital-based medicine. He also supervises and mentors residents and medical students, contributing to their clinical training and professional development. His expertise ensures high-quality patient care and medical education.

• MBBS, Medicine, King Edward Medical University, Pakistan
• MS, Clinical Research, University of Kansas Medical Center
• Residency, Internal Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas

• Internal Medicine Board Certification, ABIM
• Kansas Medical License, Kansas State Board of Healing Arts

• American College of Physicians, Member, 2019 - Present

---

• Shahzad M, Amin MK, Daver NG, Shah MV, Hiwase D, Arber DA, Kharfan-Dabaja MA, Badar T. 2024. What have we learned about TP53-mutated acute myeloid leukemia?. Blood cancer journal, 14 (1), 202
• Shahzad Moazzam, Amin Muhammad Kashif, Khalid Muhammad Fareed, Kasaeian Amir, Oskouie Iman Menbari, Yu James, Warraich Sarmad Zaman, Basharat Ahmad, Butt Atif, Zaidi Maheen, Anwar Iqra, Jaglal Michael V, Mushtaq Muhammad Umair. 2025. Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.12.018
• Shahzad M, Iqbal Q, Amin MK, Kasaiean A, Oskouie IM, Warraich SZ, Yu J, Anwar I, Jaglal M, Mushtaq MU. 2025. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older: A Systematic Review and Meta-Analysis.. Transplantation and cellular therapy
• Shahzad M, Iqbal Q, Amin MK, Irfan S, Warraich SZ, Anwar I, Dave P, Basharat A, Hebishy A, Faisal MS, Jaglal M, Mushtaq MU. 2025. Outcomes of hematopoietic stem cell transplantation in primary plasma cell leukemia: A systematic review and meta-analysis.. Leukemia research, 148, 107640
• Shahzad Moazzam, Khalid Muhammad Fareed, Amin Muhammad Kashif, Basharat Ahmad, Ammad-Ud-Din Mohammad, Park Robin, Anwar Iqra, Faisal Muhammad Salman, Jaglal Michael. 2024. Geographic and Racial Disparities in Chimeric Antigen Receptor--T Cells and Bi-specific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia
• Anwar A, Amin MK, Anwar S, Shahzad M. 2024. Bridge the Gap: Addressing Rural End-of-Life Care Disparities and Access to Hospice Services.. Journal of pain and symptom management, 68 (4), e280-e286
• Al-Ramahi JS, Shahzad M, Nguyen A, Li K, Amin MK, Ahmed N, Lutfi F, DeJarnette S, Chaudhary SG, Bansal R, Abdelhakim H, Shune L, Abdallah AO, Singh AK, Abhyankar SH, McGuirk JP, Mushtaq MU. 2023. Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.. Bone marrow transplantation
• Mushtaq MU, Shahzad M, Amin MK, Lutfi F, DeJarnette S, Al-Ramahi JS, Li K, Ahmed N, Bansal R, Abdelhakim H, Shune L, Abdallah AO, Abhyankar SH, McGuirk JP, Singh AK. 2023. Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.. Leukemia & lymphoma, 1-10
• Shahzad M, Amin MK, Bellman P, Al-Ramahi J, Noor J, Vyas A, Mahmoudjafari Z, McGuirk M, DeJarnette S, Ahmed N, Abdallah AO, Shune L, Singh AK, McGuirk JP, Abhyankar S, Mushtaq MU. 2024. Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.. Transfusion, 64 (8), 1402-1406
• McGuirk M, Shahzad M, Amin MK, Khan MA, Bellman P, Mudaranthakam DP, DeJarnette S, Lutfi F, Ahmed N, Bansal R, Abdelhakim H, Gorsline C, Shoemaker DM, Abdallah AO, Shune L, Abhyankar SH, Singh AK, McGuirk JP, Mushtaq MU. 2024. Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.. Transplant immunology, 84, 102039